About 1 result found for searched term "2445460-16-0" (0.194 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M40609 | Eblasakimab | IL Receptor/Related |
| Eblasakimab is a potential first-in-class, novel monoclonal antibody that targets the IL-13 receptor alpha 1 subunit (IL-13Rα1) and inhibits signaling of the pro-inflammatory cytokines IL-4 and IL-13. It can be used in studies related to atopic dermatitis (AD). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
